prostacyclin

DRUG3 trials

Sponsors

Catholic University of the Sacred Heart, United Therapeutics, Stanford University

Conditions

Acute Kidney FailureHeart FailurePulmonary Arterial Hypertension

Phase 4

Prostacyclin's Effect on Platelet Responsiveness

CompletedNCT00890214

Catholic University of the Sacred HeartAcute Kidney Failure

Start: 2007-09-30End: 2008-05-31Updated: 2009-04-29

Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement

CompletedNCT01717209

Stanford UniversityHeart Failure

Start: 2012-10-31End: 2013-10-31Updated: 2017-10-09

Unknown Phase

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

CompletedNCT01266265

United TherapeuticsPulmonary Arterial Hypertension

Start: 2010-12-31End: 2014-12-31Updated: 2016-02-17

Related Papers

An Observational Study of Inhaled‐Treprostinil Respiratory‐Related Safety in Patients with Pulmonary Arterial Hypertension

Pulmonary Circulation2016-06-1711 citations